Bartlett & Co Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Bartlett & Co Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-150	Closed	-$10	–	1231
2023 Q4	$10	Buy	+150	New	+$10	﹤0.01%	1235

Bartlett & Co Wealth Management's ARDS Position: Q1 2024 in Review

Bartlett & Co Wealth Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q1 2024, closing a stake of 150 shares — an estimated $10 sold.

Bartlett & Co Wealth Management first reported a position in ARDS in Q4 2023 and held it in 1 quarter. The position peaked at $10 in Q4 2023. 0 funds tracked by Wall St. Rank hold ARDS as of Q1 2024.

Bartlett & Co Wealth Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bartlett & Co Wealth Management sold 150 Aridis Pharmaceuticals Inc. Common Stock shares in Q1 2024, an estimated $10.
Bartlett & Co Wealth Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Bartlett & Co Wealth Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $10 in Q4 2023.
0 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q1 2024.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2024, filed 9 May 2024.